Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Offer Talks Terminated

27 Sep 2013 15:12

RNS Number : 1537P
W&G Investments PLC
27 September 2013
 



 

 

W&G INVESTMENTS PLC

 

 Termination of offer talks

On 27 September 2013, the board of directors of W&G Investments PLC (the "Company") was informed by the board of directors of The Royal Bank of Scotland Group plc ("RBSG") that RBSG has conclusively terminated discussions with the Company in respect of the potential acquisition of certain assets and liabilities relating to the Rainbow branches that are currently held by RBSG (the "Potential Acquisition") following the submission to RBSG of an updated proposal. Defined terms in this announcement shall have the same meaning as those set out in the Company's admission document dated 15 August 2013 ("Admission Document").

 

The final and improved proposal that the Company put to RBSG with respect to the Potential Acquisition comprised £1.1 billion in cash up front, £250 million of warrants with a return on equity strike threshold of 12.5% and additional value that may have accrued to RBSG by reference to the performance of the Rainbow business between the Signing Date and the Completion Date. The total consideration, including any additional value that would accrue to RBSG, would have amounted to up to £1.75 billion.

 

As set out in its Admission Document, the Potential Acquisition had already been identified and would constitute a reverse takeover for the purposes of the AIM Rules and, consequently, trading in the Company's Ordinary Shares was suspended on Admission. As the Company is no longer pursuing the Potential Acquisition, trading in its Ordinary Shares on AIM will shortly commence.

 

In the Admission Document the Company stated that if, within 6 months of Admission, for any reason the Company chose not or was not in a position to pursue the Potential Acquisition, the Company intended to return any remaining cash (after payment of all of its expenses) to its Shareholders by the most efficient route, seek cancellation of the Ordinary Shares from AIM and apply for a voluntary members' liquidation. Further announcements in this regard will be made when appropriate.

 

Andrew Higginson, Chairman of the Company, said: "We are disappointed that our final proposal was not accepted by the Board of RBS as we believed it offered full and fair value for the assets on offer and would have provided certain value to RBS shareholders. Nonetheless, I would like to thank all our investors for backing our offer and providing us with the financial support that brought us this far. We now intend to return the remaining cash in W&G Investments to investors with the minimum of delay. We estimate this to be approximately £10m."

Contacts:

 

 

W&G Investments PLC +44 (0) 1992 644 909 

Andrew Higginson (Non-Executive Chairman)

 

Canaccord Genuity Limited +44 (0) 20 7523 8350

 

Charles Williams (Advisory)

Bruce Garrow (Corporate Broking)

Peter Stewart (Corporate Broking)

 

Baden Hill +44 (0) 20 7448 4719

Matthew Wakefield

Maitland (PR advisers) +44 (0) 20 7379 5151

Neil BennettAndy Donald

 

 

Canaccord Genuity Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as financial adviser and nominated adviser to the Company and will not be acting for any other person or otherwise be responsible to any person for providing the protections afforded to clients of Canaccord Genuity Limited.

 

Baden Hill, which is a trading name of Fiske plc, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority and is a member of the London Stock Exchange, is acting exclusively for the Company and will not be acting for any other person or otherwise be responsible to any person for providing the protections afforded to clients of Baden Hill.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OTTUBRSROWAKUAR
Date   Source Headline
17th Apr 201911:20 amRNSSegmental Reporting Restatement Document
1st Apr 20194:30 pmRNSDirector/PDMR Shareholding
29th Mar 20195:04 pmRNSTotal Voting Rights
27th Mar 20192:05 pmRNSPublication of Final Terms
20th Mar 201910:17 amRNSRBSG pricing of US$2 billion of Senior Notes
19th Mar 20198:30 amRNSMorgan Stanley European Financials Conference
13th Mar 20196:26 pmRNSNotice of Redemption
11th Mar 20193:00 pmRNSDirector/PDMR Shareholding
7th Mar 20194:56 pmRNSForm 8.3 - Findel plc
6th Mar 20192:45 pmRNSForm 8.3 - MedicX Fund Limited
1st Mar 20191:10 pmRNSForm 8.3 - MedicX Fund Limited
1st Mar 201912:01 pmRNSDirector/PDMR Shareholding
1st Mar 20197:00 amRNSFiling of Annual Report on Form 20-F with US SEC
28th Feb 20192:25 pmRNSDividend Declaration
28th Feb 201912:40 pmRNSTotal Voting Rights
26th Feb 20195:50 pmRNSPublication of Supplementary Prospectus
22nd Feb 201912:51 pmRNSUpdate on NatWest Markets transfer scheme
22nd Feb 201912:00 pmRNSDirector/PDMR Shareholding
15th Feb 20193:00 pmRNSPublication of Supplementary Prospectus
15th Feb 20197:02 amRNSDirectorate Change
15th Feb 20197:01 amRNSAnnual Financial Report
15th Feb 20197:00 amRNSFinal Results
6th Feb 20194:16 pmRNSResult of Meeting
6th Feb 20192:55 pmRNSGM Statement
31st Jan 201911:42 amRNSTotal Voting Rights
29th Jan 20192:55 pmRNSDirector/PDMR Shareholding
25th Jan 20191:27 pmRNSForm 8.3 Disclosure
17th Jan 20194:10 pmRNSNotice of GM
9th Jan 20195:02 pmRNSHolding(s) in Company
31st Dec 20181:13 pmRNSTotal Voting Rights
28th Dec 20184:28 pmRNSDirector/PDMR Shareholding
27th Dec 20184:55 pmRNSDividend Declaration
18th Dec 20183:55 pmRNSDirectorate Change
14th Dec 20186:15 pmRNSRBS welcome credit ratings action by Fitch Ratings
14th Dec 20183:33 pmRNSPublication of a Prospectus
6th Dec 20184:40 pmRNSSecond Price Monitoring Extn
6th Dec 20184:35 pmRNSPrice Monitoring Extension
6th Dec 20182:16 pmRNSNatWest Markets transfer scheme
30th Nov 20182:30 pmRNSTotal Voting Rights
30th Nov 20181:12 pmRNSDirector/PDMR Shareholding
29th Nov 20184:28 pmRNSDividend Declaration
29th Nov 20184:07 pmRNSNotice of Redemption
29th Nov 201811:34 amRNSNotice of Rdemption
29th Nov 201811:33 amRNSNotice of Redemption
29th Nov 201811:31 amRNSNotice of Redemption
29th Nov 201811:31 amRNSNotice of Redemption
29th Nov 20188:00 amRNSRBS Investor Seminar: Commercial Banking
28th Nov 20185:09 pmRNS2018 Bank of England stress test results
16th Nov 201812:00 pmRNSDirector/PDMR Shareholding
9th Nov 20184:16 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.